A Phase 1 study of HS-20093 in advanced solid tumors
Unknown Phase 1 NCT05276609
Study Description
A study to evaluate the safety and effectiveness of an investigational drug (HS-20093) for the treatment of advanced solid tumors
Study Details
- Registry ID:
- NCT05276609
- Conditions:
- Advanced Solid Tumor
- Phase:
- Phase 1
- Target Enrollment:
- 177 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing, China
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.